nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—HTR7—epilepsy syndrome	0.0641	0.318	CbGaD
Risperidone—ADRA2A—epilepsy syndrome	0.0549	0.272	CbGaD
Risperidone—autistic disorder—Clonazepam—epilepsy syndrome	0.0514	0.144	CpDpCtD
Risperidone—bipolar disorder—Oxcarbazepine—epilepsy syndrome	0.0408	0.114	CpDpCtD
Risperidone—bipolar disorder—Lamotrigine—epilepsy syndrome	0.0408	0.114	CpDpCtD
Risperidone—bipolar disorder—Topiramate—epilepsy syndrome	0.0347	0.0968	CpDpCtD
Risperidone—HTR2A—epilepsy syndrome	0.0322	0.16	CbGaD
Risperidone—bipolar disorder—Carbamazepine—epilepsy syndrome	0.0309	0.0863	CpDpCtD
Risperidone—schizophrenia—Lamotrigine—epilepsy syndrome	0.0295	0.0823	CpDpCtD
Risperidone—CYP2D6—epilepsy syndrome	0.0295	0.146	CbGaD
Risperidone—bipolar disorder—Valproic Acid—epilepsy syndrome	0.0263	0.0734	CpDpCtD
Risperidone—bipolar disorder—Clonazepam—epilepsy syndrome	0.0247	0.069	CpDpCtD
Risperidone—schizophrenia—Carbamazepine—epilepsy syndrome	0.0224	0.0624	CpDpCtD
Risperidone—ABCB1—epilepsy syndrome	0.021	0.104	CbGaD
Risperidone—bipolar disorder—Gabapentin—epilepsy syndrome	0.0199	0.0556	CpDpCtD
Risperidone—schizophrenia—Valproic Acid—epilepsy syndrome	0.019	0.053	CpDpCtD
Risperidone—schizophrenia—Clonazepam—epilepsy syndrome	0.0179	0.0499	CpDpCtD
Risperidone—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0105	0.0518	CbGbCtD
Risperidone—CYP3A7—Carbamazepine—epilepsy syndrome	0.00882	0.0433	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00882	0.0433	CbGbCtD
Risperidone—CYP3A7—Phenytoin—epilepsy syndrome	0.00791	0.0389	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00791	0.0389	CbGbCtD
Risperidone—ABCB1—Levetiracetam—epilepsy syndrome	0.0075	0.0368	CbGbCtD
Risperidone—CYP3A7—Phenobarbital—epilepsy syndrome	0.00705	0.0347	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00705	0.0347	CbGbCtD
Risperidone—CYP3A7—Midazolam—epilepsy syndrome	0.00696	0.0342	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00696	0.0342	CbGbCtD
Risperidone—CYP3A7—Diazepam—epilepsy syndrome	0.00669	0.0329	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00669	0.0329	CbGbCtD
Risperidone—CYP3A5—Carbamazepine—epilepsy syndrome	0.00662	0.0325	CbGbCtD
Risperidone—CYP3A5—Phenytoin—epilepsy syndrome	0.00594	0.0292	CbGbCtD
Risperidone—CYP3A5—Phenobarbital—epilepsy syndrome	0.00529	0.026	CbGbCtD
Risperidone—CYP3A5—Midazolam—epilepsy syndrome	0.00522	0.0256	CbGbCtD
Risperidone—ABCB1—Clobazam—epilepsy syndrome	0.0052	0.0255	CbGbCtD
Risperidone—CYP3A5—Diazepam—epilepsy syndrome	0.00502	0.0246	CbGbCtD
Risperidone—ABCB1—Lamotrigine—epilepsy syndrome	0.005	0.0246	CbGbCtD
Risperidone—ABCB1—Carbamazepine—epilepsy syndrome	0.00431	0.0212	CbGbCtD
Risperidone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00411	0.0202	CbGbCtD
Risperidone—CYP3A5—Valproic Acid—epilepsy syndrome	0.00395	0.0194	CbGbCtD
Risperidone—ABCB1—Phenytoin—epilepsy syndrome	0.00386	0.019	CbGbCtD
Risperidone—CYP3A4—Trimethadione—epilepsy syndrome	0.00382	0.0188	CbGbCtD
Risperidone—CYP3A4—Felbamate—epilepsy syndrome	0.00382	0.0188	CbGbCtD
Risperidone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00359	0.0176	CbGbCtD
Risperidone—ABCB1—Phenobarbital—epilepsy syndrome	0.00344	0.0169	CbGbCtD
Risperidone—ABCB1—Midazolam—epilepsy syndrome	0.0034	0.0167	CbGbCtD
Risperidone—CYP2D6—Propofol—epilepsy syndrome	0.0034	0.0167	CbGbCtD
Risperidone—ABCB1—Diazepam—epilepsy syndrome	0.00326	0.016	CbGbCtD
Risperidone—CYP3A4—Clonazepam—epilepsy syndrome	0.00325	0.016	CbGbCtD
Risperidone—CYP3A4—Clobazam—epilepsy syndrome	0.00311	0.0153	CbGbCtD
Risperidone—HTR1D—meninx—epilepsy syndrome	0.00309	0.0802	CbGeAlD
Risperidone—CYP3A4—Rufinamide—epilepsy syndrome	0.00265	0.013	CbGbCtD
Risperidone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00258	0.0127	CbGbCtD
Risperidone—CYP3A4—Primidone—epilepsy syndrome	0.00241	0.0118	CbGbCtD
Risperidone—CYP3A4—Phenytoin—epilepsy syndrome	0.00231	0.0114	CbGbCtD
Risperidone—CYP3A4—Propofol—epilepsy syndrome	0.00216	0.0106	CbGbCtD
Risperidone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00206	0.0101	CbGbCtD
Risperidone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00206	0.0101	CbGbCtD
Risperidone—CYP3A4—Midazolam—epilepsy syndrome	0.00203	0.01	CbGbCtD
Risperidone—CYP3A4—Diazepam—epilepsy syndrome	0.00196	0.00961	CbGbCtD
Risperidone—CYP3A4—Zonisamide—epilepsy syndrome	0.00191	0.00938	CbGbCtD
Risperidone—HTR2A—phrenic nerve—epilepsy syndrome	0.00166	0.0431	CbGeAlD
Risperidone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00154	0.00757	CbGbCtD
Risperidone—CYP3A4—Topiramate—epilepsy syndrome	0.00139	0.00683	CbGbCtD
Risperidone—DRD3—telencephalic ventricle—epilepsy syndrome	0.00126	0.0327	CbGeAlD
Risperidone—HTR7—locus ceruleus—epilepsy syndrome	0.00119	0.0309	CbGeAlD
Risperidone—HTR7—vagus nerve—epilepsy syndrome	0.00091	0.0236	CbGeAlD
Risperidone—DRD1—telencephalic ventricle—epilepsy syndrome	0.000902	0.0234	CbGeAlD
Risperidone—HTR2A—locus ceruleus—epilepsy syndrome	0.000741	0.0193	CbGeAlD
Risperidone—HTR1B—telencephalic ventricle—epilepsy syndrome	0.000731	0.019	CbGeAlD
Risperidone—HTR1D—telencephalic ventricle—epilepsy syndrome	0.000707	0.0184	CbGeAlD
Risperidone—HTR2C—telencephalic ventricle—epilepsy syndrome	0.0007	0.0182	CbGeAlD
Risperidone—HTR7—pons—epilepsy syndrome	0.000685	0.0178	CbGeAlD
Risperidone—HTR7—autonomic nervous system—epilepsy syndrome	0.000631	0.0164	CbGeAlD
Risperidone—HTR2A—cerebellar cortex—epilepsy syndrome	0.000604	0.0157	CbGeAlD
Risperidone—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00059	0.0153	CbGeAlD
Risperidone—HTR2A—vagus nerve—epilepsy syndrome	0.000567	0.0147	CbGeAlD
Risperidone—HTR7—telencephalic ventricle—epilepsy syndrome	0.000563	0.0146	CbGeAlD
Risperidone—DRD1—ganglion—epilepsy syndrome	0.000561	0.0146	CbGeAlD
Risperidone—DRD2—telencephalic ventricle—epilepsy syndrome	0.000533	0.0138	CbGeAlD
Risperidone—HTR1B—ganglion—epilepsy syndrome	0.000455	0.0118	CbGeAlD
Risperidone—HTR1D—ganglion—epilepsy syndrome	0.00044	0.0114	CbGeAlD
Risperidone—HTR2C—ganglion—epilepsy syndrome	0.000436	0.0113	CbGeAlD
Risperidone—HTR2A—pons—epilepsy syndrome	0.000427	0.0111	CbGeAlD
Risperidone—HTR2A—autonomic nervous system—epilepsy syndrome	0.000394	0.0102	CbGeAlD
Risperidone—HTR1A—ganglion—epilepsy syndrome	0.000367	0.00954	CbGeAlD
Risperidone—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000351	0.00913	CbGeAlD
Risperidone—HTR7—ganglion—epilepsy syndrome	0.000351	0.00912	CbGeAlD
Risperidone—DRD2—ganglion—epilepsy syndrome	0.000332	0.00862	CbGeAlD
Risperidone—Paliperidone—ADRA2A—epilepsy syndrome	0.000319	0.226	CrCbGaD
Risperidone—HTR1A—hindbrain—epilepsy syndrome	0.000278	0.00724	CbGeAlD
Risperidone—HTR7—hindbrain—epilepsy syndrome	0.000266	0.00691	CbGeAlD
Risperidone—Iloperidone—HTR7—epilepsy syndrome	0.000261	0.184	CrCbGaD
Risperidone—ADRA1A—hindbrain—epilepsy syndrome	0.000257	0.00667	CbGeAlD
Risperidone—DRD2—hindbrain—epilepsy syndrome	0.000252	0.00654	CbGeAlD
Risperidone—DRD1—brainstem—epilepsy syndrome	0.000244	0.00634	CbGeAlD
Risperidone—H1F0—forebrain—epilepsy syndrome	0.000238	0.0062	CbGeAlD
Risperidone—DRD1—forebrain—epilepsy syndrome	0.000235	0.00612	CbGeAlD
Risperidone—Iloperidone—ADRA2A—epilepsy syndrome	0.000223	0.158	CrCbGaD
Risperidone—H1F0—telencephalon—epilepsy syndrome	0.000219	0.0057	CbGeAlD
Risperidone—HTR2A—ganglion—epilepsy syndrome	0.000219	0.00569	CbGeAlD
Risperidone—DRD1—telencephalon—epilepsy syndrome	0.000217	0.00563	CbGeAlD
Risperidone—HTR1B—brainstem—epilepsy syndrome	0.000198	0.00514	CbGeAlD
Risperidone—DRD4—brain—epilepsy syndrome	0.000194	0.00505	CbGeAlD
Risperidone—HTR1D—brainstem—epilepsy syndrome	0.000191	0.00498	CbGeAlD
Risperidone—HTR1B—forebrain—epilepsy syndrome	0.000191	0.00496	CbGeAlD
Risperidone—HTR2C—brainstem—epilepsy syndrome	0.00019	0.00493	CbGeAlD
Risperidone—DRD3—head—epilepsy syndrome	0.000188	0.00489	CbGeAlD
Risperidone—Paliperidone—HTR2A—epilepsy syndrome	0.000187	0.133	CrCbGaD
Risperidone—HTR1D—forebrain—epilepsy syndrome	0.000185	0.0048	CbGeAlD
Risperidone—HTR2C—forebrain—epilepsy syndrome	0.000183	0.00475	CbGeAlD
Risperidone—DRD3—nervous system—epilepsy syndrome	0.000179	0.00464	CbGeAlD
Risperidone—HTR1B—telencephalon—epilepsy syndrome	0.000175	0.00456	CbGeAlD
Risperidone—H1F0—medulla oblongata—epilepsy syndrome	0.000172	0.00448	CbGeAlD
Risperidone—DRD3—central nervous system—epilepsy syndrome	0.000172	0.00447	CbGeAlD
Risperidone—HTR2B—forebrain—epilepsy syndrome	0.000172	0.00447	CbGeAlD
Risperidone—Paliperidone—CYP2D6—epilepsy syndrome	0.000171	0.121	CrCbGaD
Risperidone—HTR1D—telencephalon—epilepsy syndrome	0.00017	0.00442	CbGeAlD
Risperidone—HTR2C—telencephalon—epilepsy syndrome	0.000168	0.00437	CbGeAlD
Risperidone—HTR2A—hindbrain—epilepsy syndrome	0.000166	0.00431	CbGeAlD
Risperidone—HTR1A—brainstem—epilepsy syndrome	0.00016	0.00415	CbGeAlD
Risperidone—HTR2B—telencephalon—epilepsy syndrome	0.000158	0.00411	CbGeAlD
Risperidone—H1F0—midbrain—epilepsy syndrome	0.000157	0.00409	CbGeAlD
Risperidone—DRD1—midbrain—epilepsy syndrome	0.000155	0.00404	CbGeAlD
Risperidone—HTR1A—forebrain—epilepsy syndrome	0.000154	0.004	CbGeAlD
Risperidone—H1F0—spinal cord—epilepsy syndrome	0.000154	0.00399	CbGeAlD
Risperidone—HTR7—brainstem—epilepsy syndrome	0.000152	0.00396	CbGeAlD
Risperidone—CYP2D6—hindbrain—epilepsy syndrome	0.000151	0.00393	CbGeAlD
Risperidone—HTR7—forebrain—epilepsy syndrome	0.000147	0.00382	CbGeAlD
Risperidone—ADRA1A—brainstem—epilepsy syndrome	0.000147	0.00382	CbGeAlD
Risperidone—ADRA1B—head—epilepsy syndrome	0.000145	0.00376	CbGeAlD
Risperidone—DRD2—brainstem—epilepsy syndrome	0.000144	0.00375	CbGeAlD
Risperidone—ADRA1A—forebrain—epilepsy syndrome	0.000142	0.00369	CbGeAlD
Risperidone—HTR1A—telencephalon—epilepsy syndrome	0.000142	0.00368	CbGeAlD
Risperidone—DRD2—forebrain—epilepsy syndrome	0.000139	0.00362	CbGeAlD
Risperidone—ADRA1B—nervous system—epilepsy syndrome	0.000137	0.00356	CbGeAlD
Risperidone—KCNH2—forebrain—epilepsy syndrome	0.000137	0.00356	CbGeAlD
Risperidone—H1F0—head—epilepsy syndrome	0.000137	0.00355	CbGeAlD
Risperidone—DRD3—brain—epilepsy syndrome	0.000136	0.00355	CbGeAlD
Risperidone—HTR7—telencephalon—epilepsy syndrome	0.000135	0.00352	CbGeAlD
Risperidone—DRD1—head—epilepsy syndrome	0.000135	0.0035	CbGeAlD
Risperidone—HTR2C—medulla oblongata—epilepsy syndrome	0.000132	0.00344	CbGeAlD
Risperidone—ADRA1B—central nervous system—epilepsy syndrome	0.000132	0.00343	CbGeAlD
Risperidone—Iloperidone—HTR2A—epilepsy syndrome	0.000131	0.0927	CrCbGaD
Risperidone—ADRA1A—telencephalon—epilepsy syndrome	0.000131	0.00339	CbGeAlD
Risperidone—H1F0—nervous system—epilepsy syndrome	0.000129	0.00336	CbGeAlD
Risperidone—DRD2—telencephalon—epilepsy syndrome	0.000128	0.00333	CbGeAlD
Risperidone—DRD1—nervous system—epilepsy syndrome	0.000128	0.00332	CbGeAlD
Risperidone—KCNH2—telencephalon—epilepsy syndrome	0.000126	0.00328	CbGeAlD
Risperidone—HTR1B—midbrain—epilepsy syndrome	0.000126	0.00328	CbGeAlD
Risperidone—H1F0—central nervous system—epilepsy syndrome	0.000125	0.00324	CbGeAlD
Risperidone—ADRA2C—telencephalon—epilepsy syndrome	0.000124	0.00323	CbGeAlD
Risperidone—DRD1—central nervous system—epilepsy syndrome	0.000123	0.0032	CbGeAlD
Risperidone—HTR1B—spinal cord—epilepsy syndrome	0.000123	0.0032	CbGeAlD
Risperidone—HTR1D—midbrain—epilepsy syndrome	0.000122	0.00317	CbGeAlD
Risperidone—H1F0—cerebellum—epilepsy syndrome	0.000122	0.00317	CbGeAlD
Risperidone—HTR2C—midbrain—epilepsy syndrome	0.000121	0.00314	CbGeAlD
Risperidone—Iloperidone—CYP2D6—epilepsy syndrome	0.00012	0.0848	CrCbGaD
Risperidone—HTR2C—spinal cord—epilepsy syndrome	0.000118	0.00306	CbGeAlD
Risperidone—HRH1—forebrain—epilepsy syndrome	0.00011	0.00286	CbGeAlD
Risperidone—HTR1B—head—epilepsy syndrome	0.000109	0.00284	CbGeAlD
Risperidone—ADRA2A—forebrain—epilepsy syndrome	0.000108	0.00281	CbGeAlD
Risperidone—HTR7—medulla oblongata—epilepsy syndrome	0.000106	0.00276	CbGeAlD
Risperidone—HTR1D—head—epilepsy syndrome	0.000106	0.00275	CbGeAlD
Risperidone—ADRA1B—brain—epilepsy syndrome	0.000105	0.00272	CbGeAlD
Risperidone—HTR2C—head—epilepsy syndrome	0.000105	0.00272	CbGeAlD
Risperidone—HTR1B—nervous system—epilepsy syndrome	0.000104	0.00269	CbGeAlD
Risperidone—HTR1A—midbrain—epilepsy syndrome	0.000102	0.00264	CbGeAlD
Risperidone—HRH1—telencephalon—epilepsy syndrome	0.000101	0.00263	CbGeAlD
Risperidone—HTR1D—nervous system—epilepsy syndrome	0.0001	0.00261	CbGeAlD
Risperidone—HTR1B—central nervous system—epilepsy syndrome	9.97e-05	0.00259	CbGeAlD
Risperidone—HTR2C—nervous system—epilepsy syndrome	9.93e-05	0.00258	CbGeAlD
Risperidone—ADRA2A—telencephalon—epilepsy syndrome	9.92e-05	0.00258	CbGeAlD
Risperidone—HTR1A—spinal cord—epilepsy syndrome	9.92e-05	0.00258	CbGeAlD
Risperidone—KCNH2—medulla oblongata—epilepsy syndrome	9.9e-05	0.00257	CbGeAlD
Risperidone—H1F0—brain—epilepsy syndrome	9.89e-05	0.00257	CbGeAlD
Risperidone—HTR2B—head—epilepsy syndrome	9.84e-05	0.00256	CbGeAlD
Risperidone—ADRA2C—medulla oblongata—epilepsy syndrome	9.77e-05	0.00254	CbGeAlD
Risperidone—DRD1—brain—epilepsy syndrome	9.77e-05	0.00254	CbGeAlD
Risperidone—HTR7—midbrain—epilepsy syndrome	9.72e-05	0.00253	CbGeAlD
Risperidone—HTR1D—central nervous system—epilepsy syndrome	9.65e-05	0.00251	CbGeAlD
Risperidone—HTR2C—central nervous system—epilepsy syndrome	9.56e-05	0.00249	CbGeAlD
Risperidone—HTR2A—brainstem—epilepsy syndrome	9.51e-05	0.00247	CbGeAlD
Risperidone—HTR7—spinal cord—epilepsy syndrome	9.48e-05	0.00246	CbGeAlD
Risperidone—HTR2B—nervous system—epilepsy syndrome	9.33e-05	0.00242	CbGeAlD
Risperidone—DRD2—midbrain—epilepsy syndrome	9.19e-05	0.00239	CbGeAlD
Risperidone—HTR2A—forebrain—epilepsy syndrome	9.18e-05	0.00239	CbGeAlD
Risperidone—KCNH2—midbrain—epilepsy syndrome	9.05e-05	0.00235	CbGeAlD
Risperidone—HTR2B—central nervous system—epilepsy syndrome	8.98e-05	0.00233	CbGeAlD
Risperidone—ADRA2C—midbrain—epilepsy syndrome	8.93e-05	0.00232	CbGeAlD
Risperidone—KCNH2—spinal cord—epilepsy syndrome	8.83e-05	0.0023	CbGeAlD
Risperidone—HTR1A—head—epilepsy syndrome	8.82e-05	0.00229	CbGeAlD
Risperidone—ADRA2C—spinal cord—epilepsy syndrome	8.71e-05	0.00226	CbGeAlD
Risperidone—CYP2D6—brainstem—epilepsy syndrome	8.66e-05	0.00225	CbGeAlD
Risperidone—HTR2A—telencephalon—epilepsy syndrome	8.44e-05	0.00219	CbGeAlD
Risperidone—HTR7—head—epilepsy syndrome	8.43e-05	0.00219	CbGeAlD
Risperidone—CYP2D6—forebrain—epilepsy syndrome	8.36e-05	0.00217	CbGeAlD
Risperidone—HTR1A—nervous system—epilepsy syndrome	8.36e-05	0.00217	CbGeAlD
Risperidone—ADRA1A—head—epilepsy syndrome	8.13e-05	0.00211	CbGeAlD
Risperidone—HTR1A—central nervous system—epilepsy syndrome	8.05e-05	0.00209	CbGeAlD
Risperidone—HTR7—nervous system—epilepsy syndrome	7.99e-05	0.00208	CbGeAlD
Risperidone—DRD2—head—epilepsy syndrome	7.97e-05	0.00207	CbGeAlD
Risperidone—HTR1B—brain—epilepsy syndrome	7.92e-05	0.00206	CbGeAlD
Risperidone—HTR1A—cerebellum—epilepsy syndrome	7.87e-05	0.00204	CbGeAlD
Risperidone—KCNH2—head—epilepsy syndrome	7.85e-05	0.00204	CbGeAlD
Risperidone—ADRA2A—medulla oblongata—epilepsy syndrome	7.8e-05	0.00203	CbGeAlD
Risperidone—ADRA2C—head—epilepsy syndrome	7.74e-05	0.00201	CbGeAlD
Risperidone—ADRA1A—nervous system—epilepsy syndrome	7.7e-05	0.002	CbGeAlD
Risperidone—HTR7—central nervous system—epilepsy syndrome	7.69e-05	0.002	CbGeAlD
Risperidone—CYP2D6—telencephalon—epilepsy syndrome	7.69e-05	0.002	CbGeAlD
Risperidone—HTR1D—brain—epilepsy syndrome	7.66e-05	0.00199	CbGeAlD
Risperidone—HTR2C—brain—epilepsy syndrome	7.59e-05	0.00197	CbGeAlD
Risperidone—DRD2—nervous system—epilepsy syndrome	7.55e-05	0.00196	CbGeAlD
Risperidone—HTR7—cerebellum—epilepsy syndrome	7.52e-05	0.00195	CbGeAlD
Risperidone—KCNH2—nervous system—epilepsy syndrome	7.44e-05	0.00193	CbGeAlD
Risperidone—ADRA1A—central nervous system—epilepsy syndrome	7.42e-05	0.00193	CbGeAlD
Risperidone—ADRA2C—nervous system—epilepsy syndrome	7.34e-05	0.00191	CbGeAlD
Risperidone—DRD2—central nervous system—epilepsy syndrome	7.27e-05	0.00189	CbGeAlD
Risperidone—ADRA1A—cerebellum—epilepsy syndrome	7.25e-05	0.00188	CbGeAlD
Risperidone—KCNH2—central nervous system—epilepsy syndrome	7.16e-05	0.00186	CbGeAlD
Risperidone—HTR2B—brain—epilepsy syndrome	7.13e-05	0.00185	CbGeAlD
Risperidone—ADRA2A—midbrain—epilepsy syndrome	7.13e-05	0.00185	CbGeAlD
Risperidone—DRD2—cerebellum—epilepsy syndrome	7.11e-05	0.00185	CbGeAlD
Risperidone—ADRA2C—central nervous system—epilepsy syndrome	7.07e-05	0.00184	CbGeAlD
Risperidone—KCNH2—cerebellum—epilepsy syndrome	7e-05	0.00182	CbGeAlD
Risperidone—ADRA2A—spinal cord—epilepsy syndrome	6.95e-05	0.00181	CbGeAlD
Risperidone—ADRA2C—cerebellum—epilepsy syndrome	6.91e-05	0.0018	CbGeAlD
Risperidone—HTR2A—medulla oblongata—epilepsy syndrome	6.63e-05	0.00172	CbGeAlD
Risperidone—HTR1A—brain—epilepsy syndrome	6.39e-05	0.00166	CbGeAlD
Risperidone—HRH1—head—epilepsy syndrome	6.29e-05	0.00164	CbGeAlD
Risperidone—ADRA2A—head—epilepsy syndrome	6.18e-05	0.00161	CbGeAlD
Risperidone—HTR7—brain—epilepsy syndrome	6.11e-05	0.00159	CbGeAlD
Risperidone—HTR2A—midbrain—epilepsy syndrome	6.06e-05	0.00158	CbGeAlD
Risperidone—ABCB1—forebrain—epilepsy syndrome	6.01e-05	0.00156	CbGeAlD
Risperidone—HRH1—nervous system—epilepsy syndrome	5.96e-05	0.00155	CbGeAlD
Risperidone—HTR2A—spinal cord—epilepsy syndrome	5.91e-05	0.00154	CbGeAlD
Risperidone—ADRA1A—brain—epilepsy syndrome	5.89e-05	0.00153	CbGeAlD
Risperidone—ADRA2A—nervous system—epilepsy syndrome	5.86e-05	0.00152	CbGeAlD
Risperidone—DRD2—brain—epilepsy syndrome	5.77e-05	0.0015	CbGeAlD
Risperidone—HRH1—central nervous system—epilepsy syndrome	5.74e-05	0.00149	CbGeAlD
Risperidone—KCNH2—brain—epilepsy syndrome	5.69e-05	0.00148	CbGeAlD
Risperidone—ADRA2A—central nervous system—epilepsy syndrome	5.64e-05	0.00147	CbGeAlD
Risperidone—ADRA2C—brain—epilepsy syndrome	5.61e-05	0.00146	CbGeAlD
Risperidone—ABCB1—telencephalon—epilepsy syndrome	5.53e-05	0.00144	CbGeAlD
Risperidone—ADRA2A—cerebellum—epilepsy syndrome	5.51e-05	0.00143	CbGeAlD
Risperidone—HTR2A—head—epilepsy syndrome	5.25e-05	0.00137	CbGeAlD
Risperidone—HTR2A—nervous system—epilepsy syndrome	4.98e-05	0.00129	CbGeAlD
Risperidone—HTR2A—central nervous system—epilepsy syndrome	4.8e-05	0.00125	CbGeAlD
Risperidone—CYP2D6—head—epilepsy syndrome	4.79e-05	0.00124	CbGeAlD
Risperidone—HTR2A—cerebellum—epilepsy syndrome	4.69e-05	0.00122	CbGeAlD
Risperidone—CYP3A4—nervous system—epilepsy syndrome	4.61e-05	0.0012	CbGeAlD
Risperidone—HRH1—brain—epilepsy syndrome	4.56e-05	0.00119	CbGeAlD
Risperidone—CYP2D6—nervous system—epilepsy syndrome	4.54e-05	0.00118	CbGeAlD
Risperidone—ADRA2A—brain—epilepsy syndrome	4.48e-05	0.00116	CbGeAlD
Risperidone—CYP3A4—central nervous system—epilepsy syndrome	4.44e-05	0.00115	CbGeAlD
Risperidone—CYP2D6—central nervous system—epilepsy syndrome	4.37e-05	0.00114	CbGeAlD
Risperidone—ABCB1—medulla oblongata—epilepsy syndrome	4.34e-05	0.00113	CbGeAlD
Risperidone—CYP2D6—cerebellum—epilepsy syndrome	4.27e-05	0.00111	CbGeAlD
Risperidone—ABCB1—midbrain—epilepsy syndrome	3.97e-05	0.00103	CbGeAlD
Risperidone—ABCB1—spinal cord—epilepsy syndrome	3.87e-05	0.00101	CbGeAlD
Risperidone—HTR2A—brain—epilepsy syndrome	3.81e-05	0.00099	CbGeAlD
Risperidone—CYP2D6—brain—epilepsy syndrome	3.47e-05	0.000902	CbGeAlD
Risperidone—ABCB1—head—epilepsy syndrome	3.44e-05	0.000895	CbGeAlD
Risperidone—ABCB1—nervous system—epilepsy syndrome	3.26e-05	0.000849	CbGeAlD
Risperidone—ABCB1—central nervous system—epilepsy syndrome	3.14e-05	0.000817	CbGeAlD
Risperidone—ABCB1—cerebellum—epilepsy syndrome	3.07e-05	0.000798	CbGeAlD
Risperidone—ABCB1—brain—epilepsy syndrome	2.5e-05	0.000649	CbGeAlD
Risperidone—Asthenia—Carbamazepine—epilepsy syndrome	9.08e-06	6.98e-05	CcSEcCtD
Risperidone—Agitation—Gabapentin—epilepsy syndrome	9.07e-06	6.97e-05	CcSEcCtD
Risperidone—Diarrhoea—Phenytoin—epilepsy syndrome	9.07e-06	6.97e-05	CcSEcCtD
Risperidone—Discomfort—Pregabalin—epilepsy syndrome	9.05e-06	6.96e-05	CcSEcCtD
Risperidone—Nausea—Fosphenytoin—epilepsy syndrome	9.04e-06	6.95e-05	CcSEcCtD
Risperidone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.02e-06	6.93e-05	CcSEcCtD
Risperidone—Erythema multiforme—Topiramate—epilepsy syndrome	9.02e-06	6.93e-05	CcSEcCtD
Risperidone—Angioedema—Gabapentin—epilepsy syndrome	9.02e-06	6.93e-05	CcSEcCtD
Risperidone—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.01e-06	6.93e-05	CcSEcCtD
Risperidone—Vomiting—Felbamate—epilepsy syndrome	8.99e-06	6.91e-05	CcSEcCtD
Risperidone—Dry mouth—Pregabalin—epilepsy syndrome	8.96e-06	6.89e-05	CcSEcCtD
Risperidone—Pruritus—Carbamazepine—epilepsy syndrome	8.95e-06	6.88e-05	CcSEcCtD
Risperidone—Rash—Felbamate—epilepsy syndrome	8.92e-06	6.86e-05	CcSEcCtD
Risperidone—Eye disorder—Topiramate—epilepsy syndrome	8.91e-06	6.85e-05	CcSEcCtD
Risperidone—Dermatitis—Felbamate—epilepsy syndrome	8.91e-06	6.85e-05	CcSEcCtD
Risperidone—Malaise—Gabapentin—epilepsy syndrome	8.9e-06	6.84e-05	CcSEcCtD
Risperidone—Tinnitus—Topiramate—epilepsy syndrome	8.89e-06	6.84e-05	CcSEcCtD
Risperidone—Vertigo—Gabapentin—epilepsy syndrome	8.87e-06	6.82e-05	CcSEcCtD
Risperidone—Headache—Felbamate—epilepsy syndrome	8.86e-06	6.81e-05	CcSEcCtD
Risperidone—Confusional state—Pregabalin—epilepsy syndrome	8.86e-06	6.81e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8.85e-06	6.8e-05	CcSEcCtD
Risperidone—Flushing—Topiramate—epilepsy syndrome	8.85e-06	6.8e-05	CcSEcCtD
Risperidone—Cardiac disorder—Topiramate—epilepsy syndrome	8.85e-06	6.8e-05	CcSEcCtD
Risperidone—Syncope—Gabapentin—epilepsy syndrome	8.85e-06	6.8e-05	CcSEcCtD
Risperidone—Leukopenia—Gabapentin—epilepsy syndrome	8.83e-06	6.79e-05	CcSEcCtD
Risperidone—Dizziness—Clonazepam—epilepsy syndrome	8.82e-06	6.78e-05	CcSEcCtD
Risperidone—Nausea—Vigabatrin—epilepsy syndrome	8.82e-06	6.78e-05	CcSEcCtD
Risperidone—Vomiting—Zonisamide—epilepsy syndrome	8.8e-06	6.77e-05	CcSEcCtD
Risperidone—Insomnia—Valproic Acid—epilepsy syndrome	8.79e-06	6.76e-05	CcSEcCtD
Risperidone—Oedema—Pregabalin—epilepsy syndrome	8.78e-06	6.75e-05	CcSEcCtD
Risperidone—Anaphylactic shock—Pregabalin—epilepsy syndrome	8.78e-06	6.75e-05	CcSEcCtD
Risperidone—Asthenia—Lamotrigine—epilepsy syndrome	8.77e-06	6.74e-05	CcSEcCtD
Risperidone—Dizziness—Phenytoin—epilepsy syndrome	8.76e-06	6.74e-05	CcSEcCtD
Risperidone—Rash—Zonisamide—epilepsy syndrome	8.73e-06	6.71e-05	CcSEcCtD
Risperidone—Infection—Pregabalin—epilepsy syndrome	8.73e-06	6.71e-05	CcSEcCtD
Risperidone—Paraesthesia—Valproic Acid—epilepsy syndrome	8.72e-06	6.71e-05	CcSEcCtD
Risperidone—Palpitations—Gabapentin—epilepsy syndrome	8.72e-06	6.7e-05	CcSEcCtD
Risperidone—Dermatitis—Zonisamide—epilepsy syndrome	8.72e-06	6.7e-05	CcSEcCtD
Risperidone—Dizziness—Oxcarbazepine—epilepsy syndrome	8.72e-06	6.7e-05	CcSEcCtD
Risperidone—Nausea—Diazepam—epilepsy syndrome	8.68e-06	6.67e-05	CcSEcCtD
Risperidone—Loss of consciousness—Gabapentin—epilepsy syndrome	8.67e-06	6.67e-05	CcSEcCtD
Risperidone—Headache—Zonisamide—epilepsy syndrome	8.67e-06	6.67e-05	CcSEcCtD
Risperidone—Dyspnoea—Valproic Acid—epilepsy syndrome	8.66e-06	6.66e-05	CcSEcCtD
Risperidone—Diarrhoea—Carbamazepine—epilepsy syndrome	8.66e-06	6.65e-05	CcSEcCtD
Risperidone—Angiopathy—Topiramate—epilepsy syndrome	8.65e-06	6.65e-05	CcSEcCtD
Risperidone—Pruritus—Lamotrigine—epilepsy syndrome	8.65e-06	6.65e-05	CcSEcCtD
Risperidone—Shock—Pregabalin—epilepsy syndrome	8.64e-06	6.64e-05	CcSEcCtD
Risperidone—Somnolence—Valproic Acid—epilepsy syndrome	8.64e-06	6.64e-05	CcSEcCtD
Risperidone—Immune system disorder—Topiramate—epilepsy syndrome	8.61e-06	6.62e-05	CcSEcCtD
Risperidone—Nervous system disorder—Pregabalin—epilepsy syndrome	8.61e-06	6.62e-05	CcSEcCtD
Risperidone—Cough—Gabapentin—epilepsy syndrome	8.61e-06	6.62e-05	CcSEcCtD
Risperidone—Thrombocytopenia—Pregabalin—epilepsy syndrome	8.6e-06	6.61e-05	CcSEcCtD
Risperidone—Mediastinal disorder—Topiramate—epilepsy syndrome	8.6e-06	6.61e-05	CcSEcCtD
Risperidone—Tachycardia—Pregabalin—epilepsy syndrome	8.57e-06	6.59e-05	CcSEcCtD
Risperidone—Chills—Topiramate—epilepsy syndrome	8.56e-06	6.58e-05	CcSEcCtD
Risperidone—Dyspepsia—Valproic Acid—epilepsy syndrome	8.55e-06	6.57e-05	CcSEcCtD
Risperidone—Convulsion—Gabapentin—epilepsy syndrome	8.55e-06	6.57e-05	CcSEcCtD
Risperidone—Skin disorder—Pregabalin—epilepsy syndrome	8.53e-06	6.56e-05	CcSEcCtD
Risperidone—Hypertension—Gabapentin—epilepsy syndrome	8.52e-06	6.55e-05	CcSEcCtD
Risperidone—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.49e-06	6.53e-05	CcSEcCtD
Risperidone—Vomiting—Clonazepam—epilepsy syndrome	8.48e-06	6.52e-05	CcSEcCtD
Risperidone—Decreased appetite—Valproic Acid—epilepsy syndrome	8.45e-06	6.49e-05	CcSEcCtD
Risperidone—Alopecia—Topiramate—epilepsy syndrome	8.43e-06	6.48e-05	CcSEcCtD
Risperidone—Vomiting—Phenytoin—epilepsy syndrome	8.43e-06	6.48e-05	CcSEcCtD
Risperidone—Rash—Clonazepam—epilepsy syndrome	8.41e-06	6.47e-05	CcSEcCtD
Risperidone—Dermatitis—Clonazepam—epilepsy syndrome	8.4e-06	6.46e-05	CcSEcCtD
Risperidone—Myalgia—Gabapentin—epilepsy syndrome	8.4e-06	6.46e-05	CcSEcCtD
Risperidone—Chest pain—Gabapentin—epilepsy syndrome	8.4e-06	6.46e-05	CcSEcCtD
Risperidone—Arthralgia—Gabapentin—epilepsy syndrome	8.4e-06	6.46e-05	CcSEcCtD
Risperidone—Nausea—Felbamate—epilepsy syndrome	8.4e-06	6.46e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.39e-06	6.45e-05	CcSEcCtD
Risperidone—Vomiting—Oxcarbazepine—epilepsy syndrome	8.38e-06	6.44e-05	CcSEcCtD
Risperidone—Fatigue—Valproic Acid—epilepsy syndrome	8.38e-06	6.44e-05	CcSEcCtD
Risperidone—Anxiety—Gabapentin—epilepsy syndrome	8.37e-06	6.44e-05	CcSEcCtD
Risperidone—Anorexia—Pregabalin—epilepsy syndrome	8.37e-06	6.44e-05	CcSEcCtD
Risperidone—Dizziness—Carbamazepine—epilepsy syndrome	8.37e-06	6.43e-05	CcSEcCtD
Risperidone—Diarrhoea—Lamotrigine—epilepsy syndrome	8.36e-06	6.43e-05	CcSEcCtD
Risperidone—Headache—Clonazepam—epilepsy syndrome	8.36e-06	6.43e-05	CcSEcCtD
Risperidone—Rash—Phenytoin—epilepsy syndrome	8.36e-06	6.42e-05	CcSEcCtD
Risperidone—Mental disorder—Topiramate—epilepsy syndrome	8.36e-06	6.42e-05	CcSEcCtD
Risperidone—Dermatitis—Phenytoin—epilepsy syndrome	8.35e-06	6.42e-05	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.34e-06	6.41e-05	CcSEcCtD
Risperidone—Rash—Oxcarbazepine—epilepsy syndrome	8.31e-06	6.39e-05	CcSEcCtD
Risperidone—Constipation—Valproic Acid—epilepsy syndrome	8.31e-06	6.39e-05	CcSEcCtD
Risperidone—Pain—Valproic Acid—epilepsy syndrome	8.31e-06	6.39e-05	CcSEcCtD
Risperidone—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.3e-06	6.38e-05	CcSEcCtD
Risperidone—Headache—Phenytoin—epilepsy syndrome	8.3e-06	6.38e-05	CcSEcCtD
Risperidone—Malnutrition—Topiramate—epilepsy syndrome	8.3e-06	6.38e-05	CcSEcCtD
Risperidone—Erythema—Topiramate—epilepsy syndrome	8.3e-06	6.38e-05	CcSEcCtD
Risperidone—Discomfort—Gabapentin—epilepsy syndrome	8.3e-06	6.38e-05	CcSEcCtD
Risperidone—Headache—Oxcarbazepine—epilepsy syndrome	8.26e-06	6.35e-05	CcSEcCtD
Risperidone—Nausea—Zonisamide—epilepsy syndrome	8.22e-06	6.32e-05	CcSEcCtD
Risperidone—Dry mouth—Gabapentin—epilepsy syndrome	8.22e-06	6.32e-05	CcSEcCtD
Risperidone—Hypotension—Pregabalin—epilepsy syndrome	8.21e-06	6.31e-05	CcSEcCtD
Risperidone—Flatulence—Topiramate—epilepsy syndrome	8.18e-06	6.29e-05	CcSEcCtD
Risperidone—Tension—Topiramate—epilepsy syndrome	8.15e-06	6.26e-05	CcSEcCtD
Risperidone—Dysgeusia—Topiramate—epilepsy syndrome	8.13e-06	6.25e-05	CcSEcCtD
Risperidone—Confusional state—Gabapentin—epilepsy syndrome	8.12e-06	6.24e-05	CcSEcCtD
Risperidone—Dizziness—Lamotrigine—epilepsy syndrome	8.08e-06	6.22e-05	CcSEcCtD
Risperidone—Nervousness—Topiramate—epilepsy syndrome	8.06e-06	6.2e-05	CcSEcCtD
Risperidone—Anaphylactic shock—Gabapentin—epilepsy syndrome	8.05e-06	6.19e-05	CcSEcCtD
Risperidone—Oedema—Gabapentin—epilepsy syndrome	8.05e-06	6.19e-05	CcSEcCtD
Risperidone—Vomiting—Carbamazepine—epilepsy syndrome	8.04e-06	6.18e-05	CcSEcCtD
Risperidone—Back pain—Topiramate—epilepsy syndrome	8.03e-06	6.17e-05	CcSEcCtD
Risperidone—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.01e-06	6.15e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8e-06	6.15e-05	CcSEcCtD
Risperidone—Infection—Gabapentin—epilepsy syndrome	8e-06	6.15e-05	CcSEcCtD
Risperidone—Muscle spasms—Topiramate—epilepsy syndrome	7.98e-06	6.14e-05	CcSEcCtD
Risperidone—Rash—Carbamazepine—epilepsy syndrome	7.98e-06	6.13e-05	CcSEcCtD
Risperidone—Dermatitis—Carbamazepine—epilepsy syndrome	7.97e-06	6.13e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.94e-06	6.11e-05	CcSEcCtD
Risperidone—Insomnia—Pregabalin—epilepsy syndrome	7.94e-06	6.11e-05	CcSEcCtD
Risperidone—Nausea—Clonazepam—epilepsy syndrome	7.92e-06	6.09e-05	CcSEcCtD
Risperidone—Headache—Carbamazepine—epilepsy syndrome	7.92e-06	6.09e-05	CcSEcCtD
Risperidone—Shock—Gabapentin—epilepsy syndrome	7.92e-06	6.09e-05	CcSEcCtD
Risperidone—Nervous system disorder—Gabapentin—epilepsy syndrome	7.9e-06	6.07e-05	CcSEcCtD
Risperidone—Paraesthesia—Pregabalin—epilepsy syndrome	7.89e-06	6.06e-05	CcSEcCtD
Risperidone—Thrombocytopenia—Gabapentin—epilepsy syndrome	7.89e-06	6.06e-05	CcSEcCtD
Risperidone—Nausea—Phenytoin—epilepsy syndrome	7.87e-06	6.05e-05	CcSEcCtD
Risperidone—Tachycardia—Gabapentin—epilepsy syndrome	7.86e-06	6.04e-05	CcSEcCtD
Risperidone—Dyspnoea—Pregabalin—epilepsy syndrome	7.83e-06	6.02e-05	CcSEcCtD
Risperidone—Nausea—Oxcarbazepine—epilepsy syndrome	7.83e-06	6.02e-05	CcSEcCtD
Risperidone—Vision blurred—Topiramate—epilepsy syndrome	7.82e-06	6.02e-05	CcSEcCtD
Risperidone—Skin disorder—Gabapentin—epilepsy syndrome	7.82e-06	6.01e-05	CcSEcCtD
Risperidone—Somnolence—Pregabalin—epilepsy syndrome	7.81e-06	6e-05	CcSEcCtD
Risperidone—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.79e-06	5.99e-05	CcSEcCtD
Risperidone—Tremor—Topiramate—epilepsy syndrome	7.78e-06	5.98e-05	CcSEcCtD
Risperidone—Vomiting—Lamotrigine—epilepsy syndrome	7.77e-06	5.98e-05	CcSEcCtD
Risperidone—Urticaria—Valproic Acid—epilepsy syndrome	7.72e-06	5.93e-05	CcSEcCtD
Risperidone—Rash—Lamotrigine—epilepsy syndrome	7.71e-06	5.93e-05	CcSEcCtD
Risperidone—Ill-defined disorder—Topiramate—epilepsy syndrome	7.7e-06	5.92e-05	CcSEcCtD
Risperidone—Dermatitis—Lamotrigine—epilepsy syndrome	7.7e-06	5.92e-05	CcSEcCtD
Risperidone—Body temperature increased—Valproic Acid—epilepsy syndrome	7.68e-06	5.9e-05	CcSEcCtD
Risperidone—Abdominal pain—Valproic Acid—epilepsy syndrome	7.68e-06	5.9e-05	CcSEcCtD
Risperidone—Anorexia—Gabapentin—epilepsy syndrome	7.68e-06	5.9e-05	CcSEcCtD
Risperidone—Anaemia—Topiramate—epilepsy syndrome	7.67e-06	5.9e-05	CcSEcCtD
Risperidone—Headache—Lamotrigine—epilepsy syndrome	7.66e-06	5.89e-05	CcSEcCtD
Risperidone—Decreased appetite—Pregabalin—epilepsy syndrome	7.63e-06	5.87e-05	CcSEcCtD
Risperidone—Agitation—Topiramate—epilepsy syndrome	7.63e-06	5.87e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.58e-06	5.83e-05	CcSEcCtD
Risperidone—Fatigue—Pregabalin—epilepsy syndrome	7.57e-06	5.82e-05	CcSEcCtD
Risperidone—Hypotension—Gabapentin—epilepsy syndrome	7.53e-06	5.79e-05	CcSEcCtD
Risperidone—Nausea—Carbamazepine—epilepsy syndrome	7.51e-06	5.78e-05	CcSEcCtD
Risperidone—Pain—Pregabalin—epilepsy syndrome	7.51e-06	5.77e-05	CcSEcCtD
Risperidone—Constipation—Pregabalin—epilepsy syndrome	7.51e-06	5.77e-05	CcSEcCtD
Risperidone—Malaise—Topiramate—epilepsy syndrome	7.49e-06	5.76e-05	CcSEcCtD
Risperidone—Vertigo—Topiramate—epilepsy syndrome	7.46e-06	5.73e-05	CcSEcCtD
Risperidone—Syncope—Topiramate—epilepsy syndrome	7.45e-06	5.72e-05	CcSEcCtD
Risperidone—Leukopenia—Topiramate—epilepsy syndrome	7.43e-06	5.71e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.34e-06	5.64e-05	CcSEcCtD
Risperidone—Palpitations—Topiramate—epilepsy syndrome	7.34e-06	5.64e-05	CcSEcCtD
Risperidone—Loss of consciousness—Topiramate—epilepsy syndrome	7.3e-06	5.61e-05	CcSEcCtD
Risperidone—Insomnia—Gabapentin—epilepsy syndrome	7.28e-06	5.6e-05	CcSEcCtD
Risperidone—Nausea—Lamotrigine—epilepsy syndrome	7.26e-06	5.58e-05	CcSEcCtD
Risperidone—Cough—Topiramate—epilepsy syndrome	7.24e-06	5.57e-05	CcSEcCtD
Risperidone—Feeling abnormal—Pregabalin—epilepsy syndrome	7.24e-06	5.56e-05	CcSEcCtD
Risperidone—Paraesthesia—Gabapentin—epilepsy syndrome	7.23e-06	5.56e-05	CcSEcCtD
Risperidone—Convulsion—Topiramate—epilepsy syndrome	7.19e-06	5.53e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.18e-06	5.52e-05	CcSEcCtD
Risperidone—Dyspnoea—Gabapentin—epilepsy syndrome	7.18e-06	5.52e-05	CcSEcCtD
Risperidone—Hypertension—Topiramate—epilepsy syndrome	7.17e-06	5.51e-05	CcSEcCtD
Risperidone—Somnolence—Gabapentin—epilepsy syndrome	7.16e-06	5.5e-05	CcSEcCtD
Risperidone—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.16e-06	5.5e-05	CcSEcCtD
Risperidone—Dyspepsia—Gabapentin—epilepsy syndrome	7.09e-06	5.45e-05	CcSEcCtD
Risperidone—Myalgia—Topiramate—epilepsy syndrome	7.07e-06	5.43e-05	CcSEcCtD
Risperidone—Arthralgia—Topiramate—epilepsy syndrome	7.07e-06	5.43e-05	CcSEcCtD
Risperidone—Chest pain—Topiramate—epilepsy syndrome	7.07e-06	5.43e-05	CcSEcCtD
Risperidone—Anxiety—Topiramate—epilepsy syndrome	7.04e-06	5.42e-05	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.02e-06	5.4e-05	CcSEcCtD
Risperidone—Decreased appetite—Gabapentin—epilepsy syndrome	7e-06	5.38e-05	CcSEcCtD
Risperidone—Discomfort—Topiramate—epilepsy syndrome	6.98e-06	5.37e-05	CcSEcCtD
Risperidone—Urticaria—Pregabalin—epilepsy syndrome	6.98e-06	5.36e-05	CcSEcCtD
Risperidone—Asthenia—Valproic Acid—epilepsy syndrome	6.97e-06	5.36e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.95e-06	5.35e-05	CcSEcCtD
Risperidone—Fatigue—Gabapentin—epilepsy syndrome	6.94e-06	5.34e-05	CcSEcCtD
Risperidone—Abdominal pain—Pregabalin—epilepsy syndrome	6.94e-06	5.34e-05	CcSEcCtD
Risperidone—Body temperature increased—Pregabalin—epilepsy syndrome	6.94e-06	5.34e-05	CcSEcCtD
Risperidone—Dry mouth—Topiramate—epilepsy syndrome	6.91e-06	5.31e-05	CcSEcCtD
Risperidone—Constipation—Gabapentin—epilepsy syndrome	6.89e-06	5.29e-05	CcSEcCtD
Risperidone—Pain—Gabapentin—epilepsy syndrome	6.89e-06	5.29e-05	CcSEcCtD
Risperidone—Pruritus—Valproic Acid—epilepsy syndrome	6.87e-06	5.28e-05	CcSEcCtD
Risperidone—Confusional state—Topiramate—epilepsy syndrome	6.83e-06	5.25e-05	CcSEcCtD
Risperidone—Oedema—Topiramate—epilepsy syndrome	6.78e-06	5.21e-05	CcSEcCtD
Risperidone—Infection—Topiramate—epilepsy syndrome	6.73e-06	5.18e-05	CcSEcCtD
Risperidone—Shock—Topiramate—epilepsy syndrome	6.67e-06	5.13e-05	CcSEcCtD
Risperidone—Diarrhoea—Valproic Acid—epilepsy syndrome	6.65e-06	5.11e-05	CcSEcCtD
Risperidone—Nervous system disorder—Topiramate—epilepsy syndrome	6.64e-06	5.11e-05	CcSEcCtD
Risperidone—Feeling abnormal—Gabapentin—epilepsy syndrome	6.64e-06	5.1e-05	CcSEcCtD
Risperidone—Thrombocytopenia—Topiramate—epilepsy syndrome	6.63e-06	5.1e-05	CcSEcCtD
Risperidone—Tachycardia—Topiramate—epilepsy syndrome	6.61e-06	5.08e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.59e-06	5.06e-05	CcSEcCtD
Risperidone—Skin disorder—Topiramate—epilepsy syndrome	6.58e-06	5.06e-05	CcSEcCtD
Risperidone—Hyperhidrosis—Topiramate—epilepsy syndrome	6.55e-06	5.04e-05	CcSEcCtD
Risperidone—Hypersensitivity—Pregabalin—epilepsy syndrome	6.47e-06	4.97e-05	CcSEcCtD
Risperidone—Anorexia—Topiramate—epilepsy syndrome	6.46e-06	4.97e-05	CcSEcCtD
Risperidone—Dizziness—Valproic Acid—epilepsy syndrome	6.42e-06	4.94e-05	CcSEcCtD
Risperidone—Urticaria—Gabapentin—epilepsy syndrome	6.4e-06	4.92e-05	CcSEcCtD
Risperidone—Body temperature increased—Gabapentin—epilepsy syndrome	6.37e-06	4.89e-05	CcSEcCtD
Risperidone—Abdominal pain—Gabapentin—epilepsy syndrome	6.37e-06	4.89e-05	CcSEcCtD
Risperidone—Hypotension—Topiramate—epilepsy syndrome	6.33e-06	4.87e-05	CcSEcCtD
Risperidone—Asthenia—Pregabalin—epilepsy syndrome	6.3e-06	4.84e-05	CcSEcCtD
Risperidone—Pruritus—Pregabalin—epilepsy syndrome	6.21e-06	4.78e-05	CcSEcCtD
Risperidone—Vomiting—Valproic Acid—epilepsy syndrome	6.18e-06	4.75e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.17e-06	4.75e-05	CcSEcCtD
Risperidone—Insomnia—Topiramate—epilepsy syndrome	6.13e-06	4.71e-05	CcSEcCtD
Risperidone—Rash—Valproic Acid—epilepsy syndrome	6.13e-06	4.71e-05	CcSEcCtD
Risperidone—Dermatitis—Valproic Acid—epilepsy syndrome	6.12e-06	4.7e-05	CcSEcCtD
Risperidone—Headache—Valproic Acid—epilepsy syndrome	6.09e-06	4.68e-05	CcSEcCtD
Risperidone—Paraesthesia—Topiramate—epilepsy syndrome	6.08e-06	4.68e-05	CcSEcCtD
Risperidone—Dyspnoea—Topiramate—epilepsy syndrome	6.04e-06	4.64e-05	CcSEcCtD
Risperidone—Somnolence—Topiramate—epilepsy syndrome	6.02e-06	4.63e-05	CcSEcCtD
Risperidone—Diarrhoea—Pregabalin—epilepsy syndrome	6.01e-06	4.62e-05	CcSEcCtD
Risperidone—Dyspepsia—Topiramate—epilepsy syndrome	5.96e-06	4.59e-05	CcSEcCtD
Risperidone—Hypersensitivity—Gabapentin—epilepsy syndrome	5.93e-06	4.56e-05	CcSEcCtD
Risperidone—Decreased appetite—Topiramate—epilepsy syndrome	5.89e-06	4.53e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.85e-06	4.5e-05	CcSEcCtD
Risperidone—Fatigue—Topiramate—epilepsy syndrome	5.84e-06	4.49e-05	CcSEcCtD
Risperidone—Dizziness—Pregabalin—epilepsy syndrome	5.81e-06	4.47e-05	CcSEcCtD
Risperidone—Pain—Topiramate—epilepsy syndrome	5.79e-06	4.45e-05	CcSEcCtD
Risperidone—Constipation—Topiramate—epilepsy syndrome	5.79e-06	4.45e-05	CcSEcCtD
Risperidone—Asthenia—Gabapentin—epilepsy syndrome	5.78e-06	4.44e-05	CcSEcCtD
Risperidone—Nausea—Valproic Acid—epilepsy syndrome	5.77e-06	4.44e-05	CcSEcCtD
Risperidone—Pruritus—Gabapentin—epilepsy syndrome	5.7e-06	4.38e-05	CcSEcCtD
Risperidone—Vomiting—Pregabalin—epilepsy syndrome	5.58e-06	4.29e-05	CcSEcCtD
Risperidone—Feeling abnormal—Topiramate—epilepsy syndrome	5.58e-06	4.29e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.54e-06	4.26e-05	CcSEcCtD
Risperidone—Rash—Pregabalin—epilepsy syndrome	5.54e-06	4.26e-05	CcSEcCtD
Risperidone—Dermatitis—Pregabalin—epilepsy syndrome	5.53e-06	4.25e-05	CcSEcCtD
Risperidone—Diarrhoea—Gabapentin—epilepsy syndrome	5.51e-06	4.24e-05	CcSEcCtD
Risperidone—Headache—Pregabalin—epilepsy syndrome	5.5e-06	4.23e-05	CcSEcCtD
Risperidone—Urticaria—Topiramate—epilepsy syndrome	5.38e-06	4.14e-05	CcSEcCtD
Risperidone—Abdominal pain—Topiramate—epilepsy syndrome	5.36e-06	4.12e-05	CcSEcCtD
Risperidone—Body temperature increased—Topiramate—epilepsy syndrome	5.36e-06	4.12e-05	CcSEcCtD
Risperidone—Dizziness—Gabapentin—epilepsy syndrome	5.33e-06	4.09e-05	CcSEcCtD
Risperidone—Nausea—Pregabalin—epilepsy syndrome	5.22e-06	4.01e-05	CcSEcCtD
Risperidone—Vomiting—Gabapentin—epilepsy syndrome	5.12e-06	3.94e-05	CcSEcCtD
Risperidone—Rash—Gabapentin—epilepsy syndrome	5.08e-06	3.9e-05	CcSEcCtD
Risperidone—Dermatitis—Gabapentin—epilepsy syndrome	5.07e-06	3.9e-05	CcSEcCtD
Risperidone—Headache—Gabapentin—epilepsy syndrome	5.05e-06	3.88e-05	CcSEcCtD
Risperidone—Hypersensitivity—Topiramate—epilepsy syndrome	4.99e-06	3.84e-05	CcSEcCtD
Risperidone—Asthenia—Topiramate—epilepsy syndrome	4.86e-06	3.74e-05	CcSEcCtD
Risperidone—Pruritus—Topiramate—epilepsy syndrome	4.79e-06	3.69e-05	CcSEcCtD
Risperidone—Nausea—Gabapentin—epilepsy syndrome	4.78e-06	3.68e-05	CcSEcCtD
Risperidone—Diarrhoea—Topiramate—epilepsy syndrome	4.64e-06	3.56e-05	CcSEcCtD
Risperidone—Dizziness—Topiramate—epilepsy syndrome	4.48e-06	3.44e-05	CcSEcCtD
Risperidone—Vomiting—Topiramate—epilepsy syndrome	4.31e-06	3.31e-05	CcSEcCtD
Risperidone—Rash—Topiramate—epilepsy syndrome	4.27e-06	3.28e-05	CcSEcCtD
Risperidone—Dermatitis—Topiramate—epilepsy syndrome	4.27e-06	3.28e-05	CcSEcCtD
Risperidone—Headache—Topiramate—epilepsy syndrome	4.24e-06	3.26e-05	CcSEcCtD
Risperidone—Nausea—Topiramate—epilepsy syndrome	4.02e-06	3.09e-05	CcSEcCtD
Risperidone—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	7.6e-07	1.14e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	7.59e-07	1.14e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—KDR—epilepsy syndrome	7.58e-07	1.14e-05	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	7.57e-07	1.14e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	7.55e-07	1.13e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CAT—epilepsy syndrome	7.51e-07	1.13e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	7.51e-07	1.13e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	7.5e-07	1.13e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—JUN—epilepsy syndrome	7.49e-07	1.13e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	7.46e-07	1.12e-05	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—AKT1—epilepsy syndrome	7.45e-07	1.12e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	7.44e-07	1.12e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	7.44e-07	1.12e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	7.43e-07	1.12e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	7.4e-07	1.11e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CASP3—epilepsy syndrome	7.38e-07	1.11e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—RELA—epilepsy syndrome	7.36e-07	1.11e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	7.35e-07	1.1e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	7.33e-07	1.1e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	7.32e-07	1.1e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	7.3e-07	1.1e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	7.3e-07	1.1e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	7.29e-07	1.1e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	7.28e-07	1.1e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	7.28e-07	1.09e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	7.27e-07	1.09e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—RELA—epilepsy syndrome	7.27e-07	1.09e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—POMC—epilepsy syndrome	7.25e-07	1.09e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	7.24e-07	1.09e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	7.22e-07	1.09e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.21e-07	1.08e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	7.21e-07	1.08e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	7.2e-07	1.08e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	7.19e-07	1.08e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	7.17e-07	1.08e-05	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	7.17e-07	1.08e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—JUN—epilepsy syndrome	7.17e-07	1.08e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	7.16e-07	1.08e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	7.13e-07	1.07e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	7.12e-07	1.07e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	7.12e-07	1.07e-05	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	7.11e-07	1.07e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	7.08e-07	1.07e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CAT—epilepsy syndrome	7.08e-07	1.06e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	7.07e-07	1.06e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	7.06e-07	1.06e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	7.06e-07	1.06e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	7.04e-07	1.06e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.03e-07	1.06e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	7.02e-07	1.06e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.99e-07	1.05e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MMP9—epilepsy syndrome	6.97e-07	1.05e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	6.91e-07	1.04e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	6.89e-07	1.04e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	6.87e-07	1.03e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	6.84e-07	1.03e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	6.82e-07	1.03e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GPX1—epilepsy syndrome	6.79e-07	1.02e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	6.79e-07	1.02e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—POMC—epilepsy syndrome	6.77e-07	1.02e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	6.76e-07	1.02e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—SRC—epilepsy syndrome	6.71e-07	1.01e-05	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.7e-07	1.01e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	6.67e-07	1e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	6.66e-07	1e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	6.66e-07	1e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	6.66e-07	1e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—POMC—epilepsy syndrome	6.65e-07	1e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—POMC—epilepsy syndrome	6.64e-07	9.99e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	6.64e-07	9.99e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	6.63e-07	9.97e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	6.63e-07	9.96e-06	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	6.61e-07	9.94e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—ALB—epilepsy syndrome	6.61e-07	9.94e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	6.6e-07	9.92e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	6.56e-07	9.86e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	6.55e-07	9.85e-06	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	6.54e-07	9.83e-06	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	6.53e-07	9.82e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	6.52e-07	9.81e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	6.52e-07	9.8e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	6.51e-07	9.78e-06	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	6.5e-07	9.77e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	6.5e-07	9.77e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	6.45e-07	9.71e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—JUN—epilepsy syndrome	6.45e-07	9.7e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	6.43e-07	9.67e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—SRC—epilepsy syndrome	6.43e-07	9.66e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GPX1—epilepsy syndrome	6.4e-07	9.62e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	6.38e-07	9.6e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—JUN—epilepsy syndrome	6.36e-07	9.57e-06	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	6.36e-07	9.57e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	6.33e-07	9.52e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.3e-07	9.48e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	6.3e-07	9.47e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	6.28e-07	9.44e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	6.26e-07	9.41e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	6.21e-07	9.34e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	6.19e-07	9.31e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	6.18e-07	9.29e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	6.14e-07	9.23e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	6.13e-07	9.21e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	6.09e-07	9.15e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	6.06e-07	9.12e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—ALB—epilepsy syndrome	6.06e-07	9.11e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	6.03e-07	9.07e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	6.01e-07	9.03e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	6.01e-07	9.03e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6e-07	9.02e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	5.99e-07	9e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.98e-07	8.99e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	5.98e-07	8.99e-06	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	5.97e-07	8.98e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AGT—epilepsy syndrome	5.96e-07	8.96e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	5.93e-07	8.92e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	5.92e-07	8.9e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	5.91e-07	8.89e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	5.89e-07	8.86e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	5.88e-07	8.84e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APOE—epilepsy syndrome	5.84e-07	8.77e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—SRC—epilepsy syndrome	5.79e-07	8.7e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	5.78e-07	8.69e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	5.77e-07	8.68e-06	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	5.76e-07	8.67e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	5.75e-07	8.64e-06	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	5.73e-07	8.62e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	5.71e-07	8.59e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—SRC—epilepsy syndrome	5.71e-07	8.58e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.7e-07	8.57e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	5.68e-07	8.54e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.64e-07	8.48e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	5.64e-07	8.47e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—TH—epilepsy syndrome	5.62e-07	8.45e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AGT—epilepsy syndrome	5.61e-07	8.44e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	5.59e-07	8.41e-06	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	5.58e-07	8.39e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	5.56e-07	8.36e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—RELA—epilepsy syndrome	5.56e-07	8.36e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	5.55e-07	8.34e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	5.53e-07	8.31e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	5.52e-07	8.3e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.5e-07	8.27e-06	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	5.49e-07	8.25e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	5.47e-07	8.22e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—RELA—epilepsy syndrome	5.46e-07	8.21e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	5.45e-07	8.2e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	5.44e-07	8.18e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	5.42e-07	8.15e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	5.4e-07	8.11e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	5.37e-07	8.07e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	5.37e-07	8.07e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	5.36e-07	8.07e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	5.36e-07	8.06e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	5.36e-07	8.05e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	5.35e-07	8.05e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	5.3e-07	7.97e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	5.28e-07	7.94e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	5.25e-07	7.9e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	5.23e-07	7.87e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	5.22e-07	7.85e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	5.21e-07	7.83e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	5.15e-07	7.75e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	5.14e-07	7.73e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	5.07e-07	7.62e-06	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	5.06e-07	7.61e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	5.02e-07	7.55e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	5.01e-07	7.54e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—POMC—epilepsy syndrome	5.01e-07	7.54e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	4.98e-07	7.5e-06	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.98e-07	7.49e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	4.98e-07	7.48e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	4.98e-07	7.48e-06	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.97e-07	7.47e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	4.95e-07	7.44e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	4.93e-07	7.42e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	4.92e-07	7.4e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	4.88e-07	7.34e-06	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.88e-07	7.33e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—JUN—epilepsy syndrome	4.87e-07	7.32e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	4.85e-07	7.29e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	4.83e-07	7.26e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	4.82e-07	7.25e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	4.81e-07	7.24e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	4.79e-07	7.21e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—JUN—epilepsy syndrome	4.78e-07	7.19e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	4.74e-07	7.12e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	4.74e-07	7.12e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—POMC—epilepsy syndrome	4.72e-07	7.1e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	4.69e-07	7.06e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.69e-07	7.05e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	4.69e-07	7.05e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	4.66e-07	7.01e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	4.65e-07	7e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.63e-07	6.96e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	4.62e-07	6.94e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	4.6e-07	6.91e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ALB—epilepsy syndrome	4.57e-07	6.87e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	4.57e-07	6.86e-06	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.53e-07	6.81e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	4.52e-07	6.8e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	4.51e-07	6.78e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.5e-07	6.77e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	4.49e-07	6.75e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	4.43e-07	6.66e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SRC—epilepsy syndrome	4.37e-07	6.57e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	4.36e-07	6.56e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.31e-07	6.48e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	4.3e-07	6.46e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SRC—epilepsy syndrome	4.29e-07	6.45e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	4.25e-07	6.4e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	4.24e-07	6.38e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	4.21e-07	6.33e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	4.19e-07	6.29e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.19e-07	6.29e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	4.18e-07	6.28e-06	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	4.17e-07	6.27e-06	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	4.15e-07	6.23e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	4.11e-07	6.19e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	4.1e-07	6.16e-06	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	4.06e-07	6.1e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—epilepsy syndrome	4e-07	6.01e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	3.99e-07	6.01e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	3.91e-07	5.88e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	3.81e-07	5.73e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	3.81e-07	5.73e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.77e-07	5.67e-06	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AKT1—epilepsy syndrome	3.68e-07	5.54e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.67e-07	5.52e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	3.6e-07	5.41e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.6e-07	5.41e-06	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AKT1—epilepsy syndrome	3.58e-07	5.38e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	3.55e-07	5.33e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	3.2e-07	4.82e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	3.09e-07	4.65e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.09e-07	4.64e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	3.08e-07	4.63e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	2.99e-07	4.5e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	2.94e-07	4.43e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AKT1—epilepsy syndrome	2.91e-07	4.37e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.82e-07	4.23e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	2.71e-07	4.08e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	2.67e-07	4.02e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	2.67e-07	4.01e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AKT1—epilepsy syndrome	2.66e-07	4e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	2.62e-07	3.93e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.46e-07	3.7e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	2.43e-07	3.65e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.01e-07	3.02e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.89e-07	2.85e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.24e-07	1.86e-06	CbGpPWpGaD
